Pyxis Oncology, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Boston, MA
PYXS chart
What traders are saying about $PYXS
Latest postsPyxis Oncology, Inc. news
- Pyxis Oncology to present cancer drug data at Barcelona symposium
Investing.com ·
- Pyxis Oncology to Present Micvotabart Pelidotin (MICVO) Phase 1 Monotherapy Data in Late-Breaking Oral Presentation and Two Poster Presentations at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Yahoo Finance ·
- One cancer drug spans three presentations, from lab tests to patient study
Stock Titan ·
- Pyxis Oncology to Present Micvotabart Pelidotin (MICVO)
GlobeNewswire ·
- Form 424B5 Pyxis Oncology Inc For: 25 October By Investing.com
Investing.com Nigeria ·
- Pyxis Oncology Stock Price Forecast. Should You Buy PYXS?
StockInvest.us ·
- Pyxis Oncology stock: Wells Fargo keeps USD 19.00 target for PYXS stock
ad-hoc-news.de ·
- Enterprise value to EBITDA forward of Pyxis Oncology, Inc. – NASDAQ:PYXS
TradingView ·
- Pyxis Oncology Announces Closing of Up to $282.6 Million Public Offering
Yahoo Finance ·
- Pyxis Oncology Announces Pricing of Up to $282.6 Million Public Offering
Yahoo Finance ·
- Pyxis Oncology stock falls on public offering announcement
Yahoo Finance ·
- Pyxis Oncology Announces Proposed Public Offering
Yahoo Finance ·
Pyxis Oncology, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $13.9M | $16.1M | – | – |
| Net income | -$79.6M | -$77.3M | -$73.8M | -$120.7M |
| Diluted EPS | $-1.28 | $-1.32 | $-1.85 | $-3.65 |
| Total assets (year end) | $91.5M | $157.2M | $173.7M | $211.4M |
| Cash and equivalents (year end) | $15.4M | $19.5M | $9.7M | $179.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Pyxis Oncology, Inc.
- Ticker
- PYXS (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Boston, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1782223
Frequently asked questions
What exchange is Pyxis Oncology, Inc. listed on?
Pyxis Oncology, Inc. trades on the Nasdaq under the ticker symbol PYXS.
What industry is Pyxis Oncology, Inc. in?
Pyxis Oncology, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Pyxis Oncology, Inc. headquartered?
Pyxis Oncology, Inc.'s business address on file with the SEC is in Boston, MA.
When does Pyxis Oncology, Inc.'s fiscal year end?
Pyxis Oncology, Inc.'s fiscal year ends on December 31.
How much revenue did Pyxis Oncology, Inc. report?
Pyxis Oncology, Inc. reported $13.9M in revenue for calendar year 2025, according to its SEC filings.